Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial
Steve M Taylor, Sarah Korwa, Angie Wu, Cynthia L Green, Betsy Freedman, Sheila Clapp, Joseph Kipkoech Kirui, Wendy P O’Meara, Festus M Njuguna
doi: https://doi.org/10.1101/2022.08.02.22278335
Steve M Taylor
1Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA
2Duke Clinical Research Institute, Durham, NC, USA
3Duke Global Health Institute, Duke University, Durham, NC, USA
MD MPHSarah Korwa
4Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya
Angie Wu
2Duke Clinical Research Institute, Durham, NC, USA
MSCynthia L Green
2Duke Clinical Research Institute, Durham, NC, USA
5Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA
PhDBetsy Freedman
1Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA
Sheila Clapp
2Duke Clinical Research Institute, Durham, NC, USA
MBAJoseph Kipkoech Kirui
4Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya
MScWendy P O’Meara
1Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA
3Duke Global Health Institute, Duke University, Durham, NC, USA
PhDFestus M Njuguna
4Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya
6Department of Child Health and Paediatrics, School of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya
MBChB MMed PhDData Availability
Data availability will be described in the final peer-reviewed manuscript
Posted August 03, 2022.
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial
Steve M Taylor, Sarah Korwa, Angie Wu, Cynthia L Green, Betsy Freedman, Sheila Clapp, Joseph Kipkoech Kirui, Wendy P O’Meara, Festus M Njuguna
medRxiv 2022.08.02.22278335; doi: https://doi.org/10.1101/2022.08.02.22278335
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial
Steve M Taylor, Sarah Korwa, Angie Wu, Cynthia L Green, Betsy Freedman, Sheila Clapp, Joseph Kipkoech Kirui, Wendy P O’Meara, Festus M Njuguna
medRxiv 2022.08.02.22278335; doi: https://doi.org/10.1101/2022.08.02.22278335
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2942)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4583)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2916)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4353)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6937)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)